New Monodentate P,C-Stereogenic Bicyclic Phosphanes
FULL PAPER
enantiomers without further purification. 1H NMR (C6D6): δ ϭ
7.47 (m, 2 H, Ar), 7.10 (m, 3 H, Ar), 5.99 (ddd, JH,P ϭ 43.5, J3,4 ϭ
bromoacetate[21] (890 mg, 3.2 mmol) in ethyl acetate (8 mL). The
crystals that precipitated (1.025 g, 71%) were recrystallized twice
7.5, J ϭ 2.4 Hz, 1 H, H-3), 5.93 (ddd, JH,P ϭ 69.0, J ϭ 7.5, J ϭ from ethyl acetate/ethyl alcohol/benzene (20:1:1) as described above
2.6 Hz, 1 H, H-4), 3.28 (m, 1 H), 2.32 (m, 1 H), 1.78 (m, 2 H), 1.43 for salt 8a to afford the diastereomerically pure salt 8aЈ (538 mg,
(m, 2 H), 1.28 (m, 2 H) ppm. 13C NMR (C6D6): δ ϭ 148.1 (d,
JC,P ϭ 1.7 Hz), 132.6 (d, JC,P ϭ 18.9 Hz), 128.5, 128.6, 128.2 (d,
J
37%, Ͼ98% ee). [α]2D0 ϭ Ϫ80.4 (c ϭ 0.34, chloroform). NMR spec-
troscopic data of 8aЈ were identical to those of 8a. HR-MS/LSIMS
C,P ϭ 6.0 Hz), 53.7 (d, JC,P ϭ 4.3 Hz, CH), 45.1 (d, JC,P ϭ 6.8 Hz, calcd. for C25H36O2P [M Ϫ Br]ϩ: 399.2453; found 399.2459.
CH), 33.7 (d, JC,P ϭ 33.5 Hz, CH2), 31.5 (d, JC,P ϭ 3.4 Hz, CH2), The remaining filtrates were combined, evaporated to dryness, and
26.0 (d, JC,P ϭ 5.1 Hz, CH2) ppm. 31P NMR (C6D6): δ ϭ 25.4 ppm.
hydrolyzed as described above, and yielded recovered 6 (355 mg,
54% calculated for starting racemic 6), [α]2D0 ϭ Ϫ2.0 (c ϭ 0.41,
chloroform), which could be recycled in the resolution process.
Hydrolysis of 8a (2.260 g, 4.7 mmol) as described above gave
(1R,3aS,6aS)-(ϩ)-6 (990 mg, 96%). [α]2D0 365.1 (c ϭ 0.55, chloro-
form).
Hydrolysis of 8aЈ (515 mg, 1.07 mmol) as described above gave
(1S,3aR,6aR)-(Ϫ)-6 (222 mg, 95%). [α]2D0 ϭ Ϫ363.6 (c ϭ 0.33,
chloroform).
Resolution of rac-4 into its Enantiomers: Crude phosphane 4
(18.8 mmol) was dissolved in ethyl acetate (50 mL). This solution
was added in one portion to a solution of (Ϫ)-menthyl bromoace-
tate[21] (5.85 g, 21.1 mmol) in ethyl acetate (10 mL) and the re-
sulting mixture was left overnight at room temperature. The pre-
cipitated crystals were collected on sintered glass, washed with ethyl
acetate/hexane (1:1), and dried under vacuum to afford a mixture
of diastereoisomeric phosphonium salts (7.430 g, 82%). Crystalliza-
tion from ethyl acetate/ethyl alcohol/benzene (20:1:1) yielded crys-
tals A (2.635 g, 29%, ee Ͼ 92%) and filtrate A. Crystals were recrys-
tallized from the same solvent mixture to afford diastereomerically
pure salt 8a (2.260 g, 25%, Ͼ98% ee) and filtrate B.
X-Ray Crystallographic Study and Crystal Data for 8aЈ: Diffraction
data were collected on a Kappa CCD diffractometer with graphite
monochromated Mo-Kα radiation. Structure was solved by direct
methods (SHELXS-97) and refined on F2 by the full-matrix, least-
squares method (SHELXL-97).[22] The non-hydrogen atoms were
refined anisotropically; hydrogen atoms were refined isotropically
with a riding model.
Compound 8a: [α]2D0 ϭ 78.1 (c ϭ 0.3, chloroform). 1H NMR
(CDCl3), δ ϭ 8.20 (m, 2 H, Ar), 7.67 (m, 1 H, Ar), 7.60 (m, 2 H,
Ar), 7.22 (ddd, JH,P ϭ 45.9, J ϭ 2.2, J ϭ 7.9 Hz, 1 H, H-3), 7.01
(ddd, JH,P ϭ 26.3, J ϭ 2.4, J ϭ 7.9 Hz, 1 H, H-2), 4.80 (dd, JH,P ϭ
13.5, JH,CH ϭ 17.4 Hz, 1 H, CHP), 4.62 (m, J ϭ 4.4 Hz, J ϭ
Formula: C25H36O2Pϩ BrϪ, M ϭ 479.42, orthorhombic, space
˚
group P212121, a ϭ 7.1060(2), b ϭ 11.3810(4), c ϭ 30.3240(10) A,
3
˚
V ϭ 2452.40(14) A , Z ϭ 4, F(000) ϭ 1008, R1 ϭ 0.0329 [I Ͼ
2σ(I)), wR2 ϭ 0.0844 for all data. The absolute configuration was
known from the reference (1S,2R,5S)-menthyl fragment.
10.9 Hz, 1 H, OCH-menthyl), 4.51 (dd, JH,P ϭ 13.1, JH,CH
ϭ
17.4 Hz, 1 H, CHP), 3.82 (m, 1 H), 3.54 (m, 1 H), 2.63 (m, 1 H),
2.15 (m, 1 H), 2.06 (m, 1 H), 1.60Ϫ1.88 (m, 7 H), 1.52 (m, 1 H),
1.36 (m, 1 H), 1.29 (m, 1 H), 0.92 (m, 2 H), 0.85 (d, J ϭ 6.5 Hz, 3
H, iPro-CH3), 0.79 (d, J ϭ 7.0 Hz, 3 H, iProϪCH3), 0.58 (d, J ϭ
CCDC-238149 contains the crystallographic data for this paper.
These data can be obtained free of charge at www.ccdc.cam.ac.uk/
conts/retrieving.html [or from the Cambridge Crystallographic
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; Fax:
ϩ44-1223-336-033; E-mail: deposit@ccdc.cam.ac.uk].
6.9 Hz, 3 H, CH3) ppm. 13C NMR (CDCl3): δ ϭ 165.2 (d, JC,P
ϭ
3.9 Hz), 163.6 (d, JC,P ϭ 20.4 Hz), 134.3 (d, JC,P ϭ 3.1 Hz), 132.6
(d, JC,P ϭ 10.7 Hz), 129.8 (d, JC,P ϭ 13.1 Hz), 120.1 (d, JC,P
84.8 Hz), 113.8 (d, JC,P ϭ 76.2 Hz), 77.7 (s), 53.3 (d, JC,P
ϭ
ϭ
(1S,3aR,6aR)-1-Phenyloctahydrocyclopenta[b]phosphole
1-Oxide
12.7 Hz), 46.4 (s), 40.3 (s, CH2), 37.7 (d, JC,P ϭ 55.0 Hz), 33.8 (s,
CH2), 31.8 (d, JC,P ϭ 54.2 Hz, CH2), 31.4 (s), 31.1 (d, JC,P
(9): Pd/C (10%, 100 mg) was added to a solution of (Ϫ)-1-phenyl-
1,3a,4,5,6,6a-hexahydrocyclopenta[b]phosphole 1-oxide [(Ϫ)-6,
218 mg, 1.0 mmol] in methanol (8 mL), and the reaction mixture
was kept under hydrogen atmosphere (balloon) at room temp. for
24 h. The mixture was then filtered through a short silica column
with methanol as eluent. The filtrate was evaporated to dryness to
yield the title compound (203 mg, 92%) as an oil. [α]2D0 ϭ Ϫ43.2
(c ϭ 0.53, chloroform). M.p. 40Ϫ42 °C. HR-MS(EI) calcd. for
C13H17PO [M]ϩ: 220.1017; found 220.1009.
ϭ
3.8 Hz, CH2), 29.5 (d, JC,P ϭ 1.5 Hz, CH2), 26.7 (d, JC,P ϭ 7.6 Hz,
CH2), 25.8 (s), 22.9 (s, CH2), 21.8 (s), 20.7 (s), 15.8 (s) ppm. 31P
NMR (CDCl3),
δ ϭ 55.6 ppm. HR-MS/LSIMS calcd. for
C25H36O2P [M Ϫ Br]ϩ: 399.2453; found 399.2436.
Filtrates A and B were combined, and the solvents were evaporated
to dryness to give a mixture of salts (4.892 g, 54%) enriched in the
1
P-epimer of 8a (ca. 40% ee). H NMR (CDCl3): δ selected signals
of the predominant epimer: 7.23 (ddd, JH,P ϭ 46.0, J ϭ 2.2 Hz,
J ϭ 8.0 Hz, 1 H, H-3), 6.90 (ddd, JH,P ϭ 29.0, J ϭ 2.3, J ϭ 7.9 Hz,
1 H, H-2), 4.60 (d, 2 H, PCH2), 4.56 (m, J ϭ 4.5 Hz, J ϭ 10.9 Hz,
1 H, OCHϪmenthyl), 0.49 (d, J ϭ 7.0 Hz, 3 H, CH3) ppm. 31P
NMR (CDCl3): δ ϭ 55.5 ppm. The mixture was dissolved in di-
chloromethane (60 mL), aqueous sodium hydroxide (10%, 50 mL)
was added, and the resulting two-phase reaction mixture was
stirred at room temp. for 3 h. The organic layer was separated, and
the aqueous layer was extracted with dichloromethane (2 ϫ
20 mL). The organic layers were combined, washed with water (2
ϫ 10 mL), dried over Na2SO4, and filtered, and the solvents were
evaporated to dryness. Column chromatography of the residue
(hexane/ethyl acetate/methanol, 5:3:1) gave enantioenriched phos-
phane oxide 6 (2.027 g, 91%, 40% ee). [α]2D5 ϭ Ϫ152.5 (c ϭ 0.42,
(1R,3aR,6aR)-1-Phenyloctahydrocyclopenta[b]phosphole (5): Re-
duction of (Ϫ)-1-phenyloctahydrocyclopenta[b]phosphole 1-oxide
[(Ϫ)-9, 191 mg, 0.87 mmol] with phenylsilane as described for 4
gave the title compound (175 mg, 98%) as an oil. 1H NMR (C6D6):
δ ϭ 7.26 (m, 2 H, Ar), 7.08 (m, 2 H, Ar), 7.01 (m, 1 H, Ar), 2.54
(m, 1 H), 2.46 (m, 1 H), 2.00 (m, 1 H), 1.46Ϫ1.80 (m, 7 H), 1.22
(m, 1 H), 0.90 (m, 1 H) ppm. 13C NMR (C6D6): δ ϭ 131.0 (d,
JC,P ϭ 14.6 Hz), 128.2, 128.0, 127.8, 46.2 (JC,P ϭ 3.4 Hz), 45.3 (d,
JC,P ϭ 12.1 Hz), 34.1 (d, JC,P ϭ 30.2 Hz, CH2), 33.9 (s, CH2), 33.8
(d, JC,P ϭ 3.4 Hz, CH2), 27.9 (d, JC,P ϭ 8.6 Hz, CH2), 26.0 (d,
JC,P ϭ 14.6 Hz, CH2) ppm. 31P NMR (C6D6): δ ϭ 7.1 ppm.
General Procedure for Palladium-Catalyzed Allylic Substitution: Di-
chloroform). The enantioenriched phosphane oxide 6 (655 mg, methyl malonate (0.76 mmol) and BSA (1 mmol) were dissolved in
3.0 mmol) was treated with phenylsilane (815 mg, 7.5 mmol) as de-
scribed above, and the resulting crude phosphane was dissolved
in ethyl acetate (2 mL) and added to a solution of (ϩ)-menthyl
THF (2 mL), and the solution was stirred at room temp. for 30 min.
It was then cooled to Ϫ20 °C, and a solution of [Pd(allyl)Cl]2 (1.25
mol %) and ligand (4 or 5, 12.5 mol %) in benzene (0.2 mL) was
Eur. J. Org. Chem. 2004, 3913Ϫ3918
2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3917